Lansforsakringar Fondforvaltning’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.1M Sell
131,916
-6,379
-5% -$3.06M 0.3% 60
2026
Q1
$68M Buy
138,295
+17,438
+14% +$9.46M 0.36% 50
2025
Q4
$70M Buy
120,857
+2,495
+2% +$1.41M 0.35% 48
2025
Q3
$57.4M Buy
118,362
+1,652
+1% +$769K 0.3% 62
2025
Q2
$47.3M Sell
116,710
-6,995
-6% -$2.92M 0.27% 75
2025
Q1
$61.6M Sell
123,705
-3,187
-3% -$1.73M 0.38% 52
2024
Q4
$66M Buy
+126,892
New +$69.8M 0.37% 52

Other funds holding TMO

Lansforsakringar Fondforvaltning's TMO Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Thermo Fisher Scientific (TMO) stake by 4.6% in Q2 2026, selling an estimated $3.06M and leaving 131,916 shares worth $66.1M. The position accounts for 0.3% of the portfolio, ranked #60.

Lansforsakringar Fondforvaltning first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $70M in Q4 2025. 2,631 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 131,916 shares of Thermo Fisher Scientific worth $66.1M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 6,379 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.06M.
  • Thermo Fisher Scientific made up 0.3% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #60 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Lansforsakringar Fondforvaltning's Thermo Fisher Scientific position peaked at $70M in Q4 2025.
  • 2,631 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.